B

BioMark Diagnostics Inc
SWB:20B

Watchlist Manager
BioMark Diagnostics Inc
SWB:20B
Watchlist
Price: 0.176 EUR -7.85% Market Closed
Market Cap: 16m EUR

Intrinsic Value

The intrinsic value of one 20B stock under the Base Case scenario is hidden EUR. Compared to the current market price of 0.176 EUR, BioMark Diagnostics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

20B Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
BioMark Diagnostics Inc

Intrinsic Value History
Dive into the past to invest in the future

20B looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 20B usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Compare 20B to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BUX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about BioMark Diagnostics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioMark Diagnostics Inc

Current Assets 159.4k
Cash & Short-Term Investments 88.6k
Receivables 70.8k
Non-Current Assets 717.2k
Long-Term Investments 3.2k
PP&E 679.9k
Other Non-Current Assets 34.1k
Efficiency

Free Cash Flow Analysis
BioMark Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioMark Diagnostics Inc

Revenue
155k CAD
Operating Expenses
-2.1m CAD
Operating Income
-2m CAD
Other Expenses
56.3k CAD
Net Income
-1.9m CAD
Fundamental Scores

20B Profitability Score
Profitability Due Diligence

BioMark Diagnostics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

BioMark Diagnostics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

20B Solvency Score
Solvency Due Diligence

BioMark Diagnostics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
hidden
Solvency
Score

BioMark Diagnostics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

20B Price Targets Summary
BioMark Diagnostics Inc

There are no price targets for 20B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

BioMark Diagnostics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BUX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one 20B stock?

The intrinsic value of one 20B stock under the Base Case scenario is hidden EUR.

Is 20B stock undervalued or overvalued?

Compared to the current market price of 0.176 EUR, BioMark Diagnostics Inc is hidden .

Back to Top